Ayako Takahashi, Bayer (R), Santen Pharmaceutical Co. (R);
Yoshikatsu Hosoda, Wakamoto Pharmaceutical Co. (F);
Masahiro Miyake, HOYA (R), Japan Alcon (R), Kowa Pharmaceutical Co. (R), Novartis Pharma K.K. (R), Wakamoto Pharmaceutical Co. (R);
Akio Oishi, Alcon (F), Alcon (R), Bayer (R), HOYA (R), Novartis Pharma K.K. (F), Novartis Pharma K.K. (R), Santen Pharmaceutical Co. (R), Tokai Optical Co. (F);
Sotaro Ooto, Alcon (R), Bayer (R), Nidek (R), Pfizer (R), Santen Pharmaceutical Co. (R), Senju Pharmaceutical Co. (R);
Akitaka Tsujikawa, Alcon (R), Alcon (F), AMO Japan (R), Bayer (F), Canon (F), Chugai Pharmaceutical Co. (R), Daiichi Sankyo Company (R), HOYA (R), HOYA (F), JFC Sales Plan (F), Johnson & Johnson (R), Kowa Pharmaceutical Co. (R), Nidek (R), Novartis Pharma K.K. (F), Otsuka Pharmaceutical Co. (R), Pfizer (R), Santen Pharmaceutical Co. (F), Senju Pharmaceutical Co. (R), Tomey Corporation (F), Wakamoto Pharmaceutical Co. (R)